지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2022.12
- 수록면
- 379 - 391 (13page)
이용수
초록· 키워드
오류제보하기
Leishmaniasis is a serious parasitic disease caused by Leishmania spp. transmitted through sandfly bites. This disease is a major public health concern worldwide. It can occur in 3 different clinical forms: cutaneous, mucocutaneous, and visceral leishmaniasis (CL, MCL, and VL, respectively), caused by different Leishmania spp. Currently, licensed vaccines are unavailable for the treatment of human leishmaniasis. The treatment and prevention of this disease rely mainly on chemotherapeutics, which are highly toxic and have an increasing resistance problem. The development of a safe, effective, and affordable vaccine for all forms of vector-borne disease is urgently needed to block transmission of the parasite between the host and vector. Immunological mechanisms in the pathogenesis of leishmaniasis are complex. IL-12-driven Th1-type immune response plays a crucial role in host protection. The essential purpose of vaccination is to establish a protective immune response. To date, numerous vaccine studies have been conducted using live/attenuated/killed parasites, fractionated parasites, subunits, recombinant or DNA technology, delivery systems, and chimeric peptides. Most of these studies were limited to animals. In addition, standardization has not been achieved in these studies due to the differences in the virulence dynamics of the Leishmania spp. and the feasibility of the adjuvants. More studies are needed to develop a safe and effective vaccine, which is the most promising approach against Leishmania infection.
목차
Abstract
INTRODUCTION
THE ROLE OF IMMUNOLOGICAL MECHANISMS IN LEISHMANIASIS
VACCINATION STRATEGIES IN LEISHMANIASIS
CONCLUDING REMARK
REFERENCES
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Cutaneous Leishmaniasis of the Eyelids : A Case Series with Molecular Identification and Literature Review
Parasites, Hosts and Diseases
2016 .12
-
Epidemiological Investigation of Asymptomatic Dogs with Leishmania Infection in Southwestern China Where Visceral Leishmaniasis is Intractable
Parasites, Hosts and Diseases
2016 .12
-
Epidemiological Aspects of Cutaneous Leishmaniasis during 2009-2016 in Kashan City, Central Iran
Parasites, Hosts and Diseases
2018 .02
-
A case of canine leishmaniasis in Korea
예방수의학회지
2015 .09
-
Clinico-Epidemiological Patterns of Cutaneous Leishmaniasis Patients Attending the Anuradhapura Teaching Hospital, Sri Lanka
Parasites, Hosts and Diseases
2017 .02
-
Visceral Leishmaniasis in Rural Areas of Alborz Province of Iran and Implication to Health Policy
Parasites, Hosts and Diseases
2015 .08
-
Genetic Diversity and Phylogenetic Analysis of the Iranian Leishmania Parasites Based on HSP70 Gene PCR-RFLP and Sequence Analysis
Parasites, Hosts and Diseases
2017 .08
-
A Novel Anti-Microbial Peptide from Pseudomonas, REDLK Induced Growth Inhibition of Leishmania tarentolae Promastigote In Vitro
Parasites, Hosts and Diseases
2020 .04
-
Recent Advances of Vaccine Adjuvants for Infectious Diseases
Immune Network
2015 .04
-
In Vitro Infectivity Assessment by Drug Susceptibility Comparison of Recombinant Leishmania major Expressing Enhanced Green Fluorescent Protein or EGFP-Luciferase Fused Genes with Wild-Type Parasite
Parasites, Hosts and Diseases
2015 .08
-
Parenteral, non-live rotavirus vaccine: recent history and future perspective
Clinical and Experimental Vaccine Research
2021 .09
-
Therapeutic Vaccines and Nucleic Acid Drugs for Cardiovascular Disease
지질·동맥경화학회지
2024 .09
-
Exploring the experience of developing COVID-19 vaccines in Iran
Clinical and Experimental Vaccine Research
2023 .01
-
Vaccines in the United States: a systematic review on history of evolution, regulations, licensing, and future challenges
Clinical and Experimental Vaccine Research
2020 .01
-
Review of COVID-19 Vaccines and Their Evidence in Older Adults
Annals of geriatric medicine and research
2021 .01
-
Analysis of physical and biological delivery systems for DNA cancer vaccines and their translation to clinical development
Clinical and Experimental Vaccine Research
2024 .04
-
Recent progress in microneme-based vaccines development against Toxoplasma gondii
Clinical and Experimental Vaccine Research
2018 .01
-
Should the COVID-19 Vaccine be Administered Simultaneously with Other Vaccines?
Infection and Chemotherapy
2021 .09
-
Advancements in Cancer Immunotherapy: The Evolution and Future of mRNA and DNA Vaccine Technologies
대한의생명과학회지
2025 .03
-
Current development of therapeutic vaccines for the treatment of chronic infectious diseases
Clinical and Experimental Vaccine Research
2024 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-ECN-0101-2023-513-000368985